Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 419, 878 (31 October 2002) | doi:10.1038/419878d
Patents limit medical potential of sequencing
Jon F. Merz1
- Center for Bioethics, University of Pennsylvania, 3401 Market Street, Suite 320, Philadelphia, Pennsylvania 19104-3308, USA
In your interesting Nature Science Update1 "24-hour genome dawns", you report on the prospect of a personal sequence in minutes, for less than $1,000. Patents will present at least two major problems to the timely adoption of these technologies2, 3.
To read this story in full you will need to login or make a payment (see right).